HIV/AIDS Despite substantial progress, the situation in West and Central Africa remains worrying. Every 3 minutes, one person in the region is infected with the Aids virus and 4.9 million people there are living with HIV. In 2019, 240,000 new infections were reported in the region, representing 14% of new infections globally1, with only 68% of people living with HIV aware of their status. Whilst the majority (85%) of people who know their HIV status receive ARV treatment, access to viral load testing remains limited, most patients who miss out do not receive 2nd line treatment and many patients are lost to follow-up. Furthermore, key populations, along with their partners and clients, account for 64 % of new infections and fuel the momentum of infection because of their difficulty in accessing care owing to stigma and, in some countries, criminalisation. Through the ATLAS, RUCHE, EMPOWER and PROSSAN projects, Solthis is continuing to develop comprehensive approaches to the fight against Aids which will enable us to achieve the 90-90-90 and then the 95-95-95 targets set by the international community that by 2030, 95% of people know their HIV status, 95% of people living with HIV have access to treatment, and 95% of people on ARV treatment have a suppressed viral load, indicating that the infection is under control. Solthis continues to promote access to screening, effective monitoring of the disease to reduce treatment failures and the mobilisation of users and civil society to adapt care to the real needs of people living with HIV. Every 3 minutes, one person is infected with the Aids virus in West and Central Africa (UNAIDS 2019) people live with HIV in West and Central Africa (UNAIDS 2019) 1. ONUSIDA, 2019 - GLOBAL AIDS UPDATE HEALTH PRIORITIES INFECTIOUS AND EMERGING DISEASES DEVELOPING COMPREHENSIVE APPROACHES TO THE FIGHT AGAINST HIV/AIDS Avec les projets ATLAS, RUCHE, EMPOWER, PROSSAN, Solthis poursuit son action et continue à développer des approches globales de lutte contre le sida qui permettent d’atteindre l’objectif des trois 90 puis des trois 95 fixés par la communauté internationale à savoir que d’ici à 2030, 95 % des personnes connaissent leur statut sérologique, 95 % des personnes séropositives aient accès aux traitements, et 95 % des personnes traitées aient une charge virale supprimée, signe que l’infection est sous contrôle. Solthis poursuit son action pour l’accès au dépistage, au suivi efficace de la maladie pour réduire les échecs thérapeutiques et la mobilisation des usager·ère·s et de la société civile pour adapter les soins aux besoins réels des personnes vivant avec le VIH.